WHO Certifies Shortage of Malaria Drug Supply
From Times Staff and Wire Reports
The World Health Organization said a massive shortfall in a key malaria drug was now certain, leaving poor countries with about half of what they needed to fight the disease next year.
The WHO said it planned to ration supplies of the drug. Chinese suppliers were unable to deliver sufficient quantities of a key natural ingredient, artemisinin, to Swiss drug firm Novartis, maker of the WHO’s preferred malaria-fighting drug, the U.N. health body said.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
